<DOC>
	<DOCNO>NCT01442090</DOCNO>
	<brief_summary>Study PIM4973g multicenter , international , open-label Phase II trial . Participants metastatic renal cell carcinoma progress VEGF target therapy randomize 1:1 two group either receive daily GDC-0980 everolimus orally .</brief_summary>
	<brief_title>Study GDC-0980 Versus Everolimus Participants With Metastatic Renal Cell Carcinoma Who Have Progressed Following Vascular Endothelial Growth Factor- ( VEGF ) Targeted Therapy</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Endothelial Growth Factors</mesh_term>
	<criteria>Histologically cytologically document , incurable metastatic renal cell carcinoma clearcell component progress within 6 month stop VEGFtargeted therapy Disease measurable per Response Evaluation Criteria Solid Tumors Version 1.1 ( RECIST v1.1 ) Karnofsky performance status great equal ( &gt; = ) 70 percent ( % ) Adequate hematologic end organ function For female participant childbearing potential male participant partner childbearing potential , agreement use two effective form contraception continue use duration study Any anticancer therapy , include chemotherapy , biologic target therapy , herbal therapy , hormonal therapy , radiotherapy , within 5 halflives ( systemic agent ) 2 week , whichever short , prior Day 1 . Certain forms radiation therapy may consider pain palliation participant derive benefit Previously establish diagnosis pulmonary fibrosis cause New York Heart Association ( NYHA ) Class II great congestive heart failure History malabsorption syndrome condition would interfere enteral absorption Presence positive test result hepatitis B ( hepatitis B [ HB ] surface antigen [ HBsAg ] and/or total HB core antibody [ antiHBc ; test require ] ) hepatitis C Known human immunodeficiency virus ( HIV ) infection Pregnancy , lactation , breastfeed Major surgical procedure significant traumatic injury within 28 day prior Day 1 anticipation need major surgery course study treatment Leptomeningeal disease manifestation cancer History malignancies less equal &lt; = 5 year Day 1 except tumor negligible risk metastasis death , adequately control basal cell carcinoma squamous cell carcinoma skin carcinoma situ cervix Need current chronic corticosteroid therapy ( &gt; = 10 milligram [ mg ] prednisone per day equivalent dose antiinflammatory corticosteroid great [ &gt; ] 7 day ) use immunosuppressant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>